Consequently, the AE protein is able to enhance self‐renewal and retain undifferentiated properties in hematopoietic cells by altering the expression of multiple AML1 target genes, and contributes as a driver hit in promoting AML development. This evidence concerns the gene RUNX1 and acute myeloid leukemia.